| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 150.32M | — |
| Operating expense | — | — |
| Net income | 25.49M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 12V.F returned +34.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -2.7% |
| 1 year | +34.4% |
| 5 years | -14.5% |
| 10 years | +619.0% |
| All-time high | €52.34 (Jun 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in 12V.F would be worth today ›No. Veracyte, Inc. has not paid a dividend in the past 12 months.
Veracyte, Inc. is part of the Healthcare sector.
Veracyte, Inc. has a market cap of 2.83B EUR, based on the latest quote.
